Gainers

• NRX Pharmaceuticals (NASDAQ:NRXP) shares rose 9.6% to $0.42 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 82.9K shares, which is 27.5 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $29.3 million.
• Orchestra BioMed Hldgs (NASDAQ:OBIO) stock moved upwards by 7.65% to $7.87. The company's market cap stands at $281.3 million.
• NeuBase Therapeutics (NASDAQ:NBSE) shares rose 7.4% to $2.03. The market value of their outstanding shares is at $3.8 million.
• Matinas BioPharma Hldgs (AMEX:MTNB) shares moved upwards by 6.14% to $0.4. The market value of their outstanding shares is at $87.4 million.
• Minerva Surgical (NASDAQ:UTRS) stock moved upwards by 5.34% to $0.26. The market value of their outstanding shares is at $45.9 million.
• Omega Therapeutics (NASDAQ:OMGA) stock moved upwards by 5.08% to $5.37. The market value of their outstanding shares is at $295.4 million.

Losers

• CryoPort (NASDAQ:CYRX) shares declined by 24.9% to $14.56 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 282.4K shares, which is 60.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $663.1 million.
• Petros Pharma (NASDAQ:PTPI) stock declined by 12.67% to $3.31. At the close, Petros Pharma's trading volume reached 832.3K shares. This is 31.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.9 million.
• Healthcare Triangle (NASDAQ:HCTI) stock fell 11.3% to $5.5. Trading volume for this security closed at 7.9 million, accounting for 20927.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $23.5 million.
• Redhill Biopharma (NASDAQ:RDHL) stock fell 10.13% to $1.42. The company's market cap stands at $5.6 million.
• Connect Biopharma Hldgs (NASDAQ:CNTB) shares declined by 9.09% to $1.1. The company's market cap stands at $60.5 million.
• Freeline Therapeutics (NASDAQ:FRLN) shares fell 8.7% to $5.25. At the close, Freeline Therapeutics's trading volume reached 234.9K shares. This is 154.8% of its average volume over the last 100 days. The company's market cap stands at $22.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.